Dr. Michael Anthony Carducci, MD

Dr. Carducci practices at Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland.

Dr. Carducci's NPI, 1952369977, was assigned on May 1, 2006. Dr. Carducci graduated from Wayne State University School Of Medicine in 1988. Dr. Carducci holds Maryland license D42979.

Dr. Carducci's primary practice is Johns Hopkins Hospital Nelson/Harvey Building, at 600 N Wolfe St, Baltimore, MD 21287 in Baltimore City. The practice phone is (855) 662-3017.

Dr. Carducci's primary practice is Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland. Dr. Carducci is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Carducci to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Carducci practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Carducci's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Carducci is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Carducci's licenses on file in 4 states: Maryland, District of Columbia, Virginia and Colorado.

Dmand AI lists prostate cancer among the conditions Dr. Carducci treats.

CMS data shows 580 Medicare services from Dr. Carducci across 4 procedure codes in 2024, for 247 Medicare patients. Medicare paid $59,689 for them.

CMS counts 247 Medicare patients who saw Dr. Carducci in 2024. The largest group is 65 to 74, with 110 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Carducci's median patient age at 77, with 2% women.

In 2024, Dr. Carducci wrote 613 Medicare Part D claims for 92 patients. 84% of them were for generic drugs. CMS names the drug for 492 of them, across 8 drugs with 11 or more claims each, at $1,373,844 in total drug cost. In 2023, CMS named 377 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Carducci for performance year 2024, reported as part of a group. CMS lists Dr. Carducci as offering telehealth.

Dmand AI links 434 papers to Dr. Carducci, published from 2006 to 2025. 2019 was the busiest year, with 19. The most frequent topics are Prostatic Neoplasms, Antineoplastic Agents and Prostate-Specific Antigen. Dr. Carducci has published most often in J Clin Oncol. Dr. Carducci's most frequent co-authors are Mario Eisenberger, MD, Channing Paller, MD and Samuel Ray Denmeade, MD.

Dmand AI links Dr. Carducci to 28 clinical trials, 10 of them phase 2 studies. 5 are still active or recruiting. Conditions studied include Prostatic Neoplasms, Prostatic Diseases and Carcinoma, Renal Cell. National Cancer Institute (NCI) sponsors the most, 7.

CMS Open Payments shows 67 general payments to Dr. Carducci from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 89% of the total. Pfizer Inc. paid the most, $25,927. It also lists 3 research payments totaling $4,802 in 2025.

Dmand AI lists 1 award for Dr. Carducci, most recently CMS Stage 1 EHR in 2013.

Dr. Carducci graduated from Wayne State University School Of Medicine in 1988.

Dr. Carducci is in network with 9 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.